What cannabis operators need to know this month

This Month in Focus

Three storylines worth your attention

1. The DEA rescheduling process is now concrete

For the first time since this began, operators can see what federal rescheduling will actually require of them. The DEA published a list of questions that cannabis businesses will have to answer to register for federal rescheduling protections. Separately, the administrative hearing is wrapping up: the judge released a 2,500-page transcript, ordered 294 corrections, and there is at least one un-discredited opposition witness that could still complicate the ruling.

Three months ago this was a legal abstraction. Now there is a document trail, a witness list, and a registration checklist. If you have been waiting for something specific to plan around, this is that something.

2. The hemp fight moves into federal court

Missouri is now defending its hemp product ban against a federal industry lawsuit. Whatever the outcome, this is the case likely to produce the precedent that shapes hemp regulation nationally. Meanwhile, Viola's founder went public this month arguing that hemp bans crush the operators who follow the rules while leaving the actual bad actors unaffected, and Michigan's GOP gubernatorial nominee is running on a platform that includes ending unregulated hemp sales.

What was scattered state enforcement in August has become federal litigation and a live campaign issue in one of the largest cannabis markets in the country. Licensed operators competing against hemp THC finally have a coordinated fight to track.

3. Curaleaf-Aurora and the "3-5 players per market" endgame

Curaleaf's tender offer for Aurora Cannabis is the headline. The analytical frame around it is the bigger story: mg Magazine is now arguing openly that every mature cannabis market narrows to three to five players, and the deals happening this fall are locking in who those players will be.

Combined with August's SNDL-Parallel deal, the pattern is clear. Consolidation is no longer a possibility to plan for. It is the current operating environment. Operators who have not looked up from daily execution to ask where they sit in the shakeout are already behind operators who have.

Worth Your Time

Six pieces that earned their place in your inbox

Regulation & Policy

Business & Markets

Operations & Compliance

Smart Take of the Month

Pharma and agriculture are eyeing the industry

Worth your time this month: Marijuana Moment's op-ed "Federal Rescheduling Sets the Stage for Marijuana Business Acquisitions as Pharma and Ag Firms Eye Industry" The piece argues that the next wave of cannabis acquirers is not going to look like the current wave. Pharmaceutical companies and agricultural firms have capital structures, distribution capabilities, and regulatory experience that existing cannabis operators cannot match. Once rescheduling opens the door, the M&A landscape gets a lot more crowded and a lot less predictable.

The takeaway for operators: if you have been imagining an exit to a larger cannabis MSO, expand the aperture. The buyer you should be building for may not be in the industry yet. That changes what makes your business attractive, how you position your data and operational maturity, and which relationships are worth investing in now.

On the Calendar

What's coming in the next 30 to 45 days

• Early September: Congress returns from recess. The hemp provisions in the spending bill get their first real test, and SAFE Banking supporters will look for procedural openings on either standalone action or attachment.
• Mid-September: Q3 MSO earnings previews. Read the pre-announcement guidance and analyst reaction closely, especially any commentary on the pace of consolidation and how operators are positioning around it.
• Late September: DEA administrative law judge's expected ruling window opens. Even a partial ruling will move the calendar for everyone downstream.
• Throughout October: Full MSO Q3 earnings season. Watch for consolidation commentary in the calls and any hints about who is or is not in active M&A discussions.
• Looking ahead: 2027 state ballot petition deadlines in several markets, and MJBizCon Las Vegas final registration window. If you have not booked travel and rooms, the pattern from last year suggests doing it now.

One Thing to Try

Map your competitive landscape honestly

If mg Magazine's "3-5 players per market" thesis is even directionally right, the most valuable exercise this month is knowing where you actually sit in your market. Not where you tell your board you sit. Where you actually sit.

Take a single sheet of paper. List the top ten operators in your primary market. Then for each one, mark:

1. Consolidator, survivor, or exit target, based on what they have been doing over the last 12 months.
2. One visible sign of strength (capital access, real estate, distribution, brand, operational maturity).
3. One visible sign of strain (layoffs, closed stores, missed earnings, permit issues, staff turnover).

Then put your own operation in the same list, and mark it the same way. Most operators can name every competitor's problems and none of their own. The exercise takes an hour and produces the single most useful strategic document you will have going into Q4 planning conversations.